Related Experiment Video

Updated: Nov 19, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K

Managing children with brain tumors during the COVID-19 era: Don't stop the care!

Michele Antonio Capozza1, Silvia Triarico1, Giorgio Attinà1

  • 1Pediatric Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy.

Computational and Structural Biotechnology Journal
|January 28, 2021
PubMed

Insights

The COVID-19 pandemic disrupted pediatric cancer care, necessitating prompt diagnosis and treatment. Multidisciplinary tumor boards are crucial for managing pediatric cancer patients during the pandemic, ensuring continued care and minimizing stress.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has significantly impacted global healthcare systems, leading to disruptions in cancer care services and treatment delays.
  • Pediatric populations exhibit milder COVID-19 symptoms compared to adults, potentially due to lower susceptibility.
  • Guidelines from scientific societies and governments emphasize continuing cancer treatment while warning against SARS-CoV-2 (the virus causing COVID-19) exposure.

Purpose of the Study:

  • To outline optimal diagnostic and therapeutic strategies for pediatric cancer patients during the COVID-19 pandemic.
  • To highlight the importance of multidisciplinary tumor boards in cancer care management.
  • To underscore the need for prompt diagnosis and family support to reduce patient suffering and maintain healthcare system trust.

Main Methods:

  • Regular convening of multidisciplinary tumor boards, utilizing teleconferencing and telematics platforms.
  • Emphasis on prompt diagnostic workup for pediatric cancer patients.
  • Provision of adequate information and support to patients and families regarding infection prevention and symptom reporting.

Main Results:

  • Multidisciplinary tumor boards facilitate informed decision-making for pediatric cancer management during the pandemic.
  • Timely diagnosis and treatment adjustment are critical for improving outcomes and patient confidence.
  • Effective communication and support systems help mitigate parental anxiety and stress.

Conclusions:

  • Continued cancer treatment and regular multidisciplinary team consultations are vital for pediatric patients during the COVID-19 pandemic.
  • Prompt diagnosis and supportive care are essential for minimizing suffering and maintaining trust in the healthcare system.
  • Proactive measures to prevent SARS-CoV-2 infection in pediatric cancer patients and their families are crucial for facilitating early diagnosis and treatment.

Keywords:
Brain tumorsCOVID-19CareChildren

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.7K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

581

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
314
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
210
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
110
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
864